P W Armstrong

发表

Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.

E W Steyerberg, M L Simoons, K S Pieper, 2000, Circulation.

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

G Barbash, R. Califf, P. Janský, 1999, The Lancet.

Evaluation of the Heart and Stroke Foundation of Canada Research Scholarship Program: research productivity and impact.

P. Armstrong, P. Olley, P W Armstrong, 1997, The Canadian journal of cardiology.

Low doses vs. high doses of the angiotensin converting‐enzyme inhibitor lisinopril in chronic heart failure: a cost‐effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study

P A Poole-Wilson, P. Poole‐Wilson, P. Armstrong, 2000, European journal of heart failure.

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

P A Poole-Wilson, P. Poole‐Wilson, P. Armstrong, 1999, Circulation.

A predictive index for length of stay in the intensive care unit following cardiac surgery.

C D Naylor, J V Tu, C Levinton, 1994, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure.

P. Armstrong, S. Ford, A. D. de Bold, 1986, Circulation.

Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction.

M Gent, P. Armstrong, M. Gent, 1989, Journal of the American College of Cardiology.

Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

L Pilote, E J Topol, David P Miller, 1995, The New England journal of medicine.

Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators.

F Van de Werf, M L Simoons, E J Topol, 1996, Journal of the American College of Cardiology.

Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease

C. Held, P. Armstrong, H. White, 2018, Journal of internal medicine.

Cost effectiveness of early discharge after uncomplicated acute myocardial infarction.

F Van de Werf, T D Thompson, E L Eisenstein, 2000, The New England journal of medicine.

A systematic review of randomized trials of disease management programs in heart failure.

P. Armstrong, F. McAlister, K. Teo, 2001, The American journal of medicine.

Detection of silent myocardial ischemia in diabetes mellitus.

G Steiner, P. Armstrong, A. Langer, 1991, The American journal of cardiology.

Insights into the contemporary epidemiology and outpatient management of congestive heart failure.

P. Armstrong, F. McAlister, K. Teo, 1999, American heart journal.